Tepezza, Tezspire growing Key Peptide Products: MariTide (maridebart cafraglutide GLP-1R agonist/GIPR antagonist peptide-antibody conjugate, Phase 2/3 pipeline for obesity), Nplate (romiplostim Fc-peptide fusion for ITP), Tezspire (tezepelumab, with AstraZeneca), Aimovig (erenumab CGRP receptor mAb for migraine) Therapeutic Segments: General Medicine (Repatha, Aimovig, Otezla)
Cannot redeclare control with same name "grid_1_alignment_tablet"
How are digital health technologies impacting IV glutathione treatment providers?Digital health platforms facilitate appointment scheduling, treatment monitoring, patient education, and teleconsultations
Research documents GABA modulation, BDNF expression, and immunomodulatory activity
Blue zones: lessons from the world's longest lived
Pharma partnerships